---
title: "Deutsche Bank  Sticks to Their Buy Rating for Novartis AG (NOVN)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/284552232.md"
description: "Deutsche Bank analyst Emmanuel Papadakis has reaffirmed a Buy rating for Novartis AG (NOVN) with a price target of CHF135.00. Papadakis, a 4-star analyst with a 51.26% success rate, also covers other healthcare stocks. Additionally, Morgan Stanley's Thibault Boutherin issued a Buy rating for Novartis AG, while Goldman Sachs maintained a Sell rating on the stock."
datetime: "2026-04-29T10:40:55.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/284552232.md)
  - [en](https://longbridge.com/en/news/284552232.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/284552232.md)
---

# Deutsche Bank  Sticks to Their Buy Rating for Novartis AG (NOVN)

Deutsche Bank analyst Emmanuel Papadakis maintained a Buy rating on Novartis AG today and set a price target of CHF135.00.

### Claim 55% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

According to TipRanks, Papadakis is a 4-star analyst with an average return of 3.5% and a 51.26% success rate. Papadakis covers the Healthcare sector, focusing on stocks such as AstraZeneca, GlaxoSmithKline, and Roche Holding AG.

In addition to Deutsche Bank , Novartis AG also received a Buy from Morgan Stanley’s Thibault Boutherin in a report issued yesterday. However, today, Goldman Sachs maintained a Sell rating on Novartis AG (Six Swiss: NOVN).

### Related Stocks

- [NOT.DE](https://longbridge.com/en/quote/NOT.DE.md)
- [NVS.US](https://longbridge.com/en/quote/NVS.US.md)
- [DB.US](https://longbridge.com/en/quote/DB.US.md)
- [DBK.DE](https://longbridge.com/en/quote/DBK.DE.md)
- [AZN.US](https://longbridge.com/en/quote/AZN.US.md)
- [AZN.UK](https://longbridge.com/en/quote/AZN.UK.md)
- [GSK.US](https://longbridge.com/en/quote/GSK.US.md)
- [GSK.UK](https://longbridge.com/en/quote/GSK.UK.md)
- [RHHVF.US](https://longbridge.com/en/quote/RHHVF.US.md)
- [RHHBY.US](https://longbridge.com/en/quote/RHHBY.US.md)
- [MS.US](https://longbridge.com/en/quote/MS.US.md)
- [GS.US](https://longbridge.com/en/quote/GS.US.md)
- [03KB.DE](https://longbridge.com/en/quote/03KB.DE.md)
- [DPB.DE](https://longbridge.com/en/quote/DPB.DE.md)
- [GSK.WI.US](https://longbridge.com/en/quote/GSK.WI.US.md)
- [MS-O.US](https://longbridge.com/en/quote/MS-O.US.md)
- [MS-Q.US](https://longbridge.com/en/quote/MS-Q.US.md)
- [MS-E.US](https://longbridge.com/en/quote/MS-E.US.md)
- [MS-I.US](https://longbridge.com/en/quote/MS-I.US.md)
- [MS-L.US](https://longbridge.com/en/quote/MS-L.US.md)
- [MS-P.US](https://longbridge.com/en/quote/MS-P.US.md)
- [MS-A.US](https://longbridge.com/en/quote/MS-A.US.md)
- [MS-F.US](https://longbridge.com/en/quote/MS-F.US.md)
- [MS-K.US](https://longbridge.com/en/quote/MS-K.US.md)
- [W4VR.SG](https://longbridge.com/en/quote/W4VR.SG.md)

## Related News & Research

- [Farther Finance Advisors LLC Raises Stake in Novartis AG $NVS](https://longbridge.com/en/news/283109774.md)
- [Novartis CEO Says 'Very Constructive' Engagement With Swiss Government Being Had On Finding Solution Around US MFN Policy](https://longbridge.com/en/news/284321540.md)
- [LifeSci Capital Sticks to Their Buy Rating for MoonLake Immunotherapeutics (MLTX)](https://longbridge.com/en/news/286649191.md)
- [Damora Therapeutics (DMRA) Receives a Rating Update from a Top Analyst](https://longbridge.com/en/news/286678740.md)
- [LifeSci Capital Sticks to Its Buy Rating for Neurogene (NGNE)](https://longbridge.com/en/news/286648209.md)